Sells sleep and breathing devices, masks and connected health software to home medical equipment providers, hospitals and patients.
10-K for FY2026, filed Aug 13, 2026Following our formation in 1989, we commercialized a continuous positive airway pressure, or CPAP, treatment for obstructive sleep apnea…View ↗
United States, Canada, and Latin America or "Americas". Our products are typically purchased by an HME provider who then sells the products…View ↗
Combined Europe, Asia, and other markets or "Rest of World". We market our products in most major countries in Rest of World geographies.…View ↗
Medical equipment customers pay for sleep and breathing products when they ship. Residential care providers pay for hosted software as services are delivered, with access, support and maintenance also sold for an agreed term.
10-K for FY2026, filed Aug 13, 2026
10-K for FY2026, filed Aug 13, 2026
FY2026 revenue by product or service ↗$5.7B
10-K for FY2026, filed Aug 13, 2026
$5.7B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Sleep and Breathing Health
Sold outright
10-K for FY2026, filed Aug 13, 2026 |
88%
FY2023: 88%
|
Sleep and Breathing Health, FY2026
$5B Sources
|
Sold outright |
|
Residential Care Software
Recurring
10-K for FY2026, filed Aug 13, 2026 |
12%
FY2023: 12%
|
Residential Care Software, FY2026
$675.8M Sources
|
Recurring |
Home medical equipment providers buy sleep and breathing products and resell them to patients; hospitals and independent distributors also sell the products. Residential care providers generally buy software directly, while some add-on solutions are sold through sales partners.
10-K for FY2026, filed Aug 13, 2026United States, Canada, and Latin America or "Americas". Our products are typically purchased by an HME provider who then sells the products…View ↗
Combined Europe, Asia, and other markets or "Rest of World". We market our products in most major countries in Rest of World geographies.…View ↗
Residential Care Software. Our Residential Care Software solutions are sold to providers of healthcare in various residential care…View ↗
We develop, market, and sell our MEDIFOX DAN care management and related digital solutions to providers in Germany, including home care…View ↗
Yes. It kept 27 cents of every revenue dollar as net income in FY2026 and turned 29 cents into free cash flow.
10-Q for Q1 FY2027, filed Oct 30, 2026
$418.4MView ↗
10-Q for Q1 FY2027, filed Oct 30, 2026
Open tableView ↗
8-K, filed Aug 17, 2026
KPMG LLP (“KPMG”) was previously the principal accountants for ResMed Inc. (the “Company” or “Resmed”). On August 13, 2026, KPMG was…View ↗
Growing. Revenue grew 58% in 4 years, from $3.6B in FY2022 to $5.7B in FY2026, about 12% a year.
Agrees to sell MatrixCare
The earlier report described software sold through its MatrixCare subsidiary; the latest report says ResMed has agreed to sell MatrixCare and related software offerings.
10-K for FY2023, filed Aug 11, 2023 10-K for FY2026, filed Aug 13, 2026Since formation we have acquired a number of businesses, including distributors, suppliers, developers of medical equipment and related…View ↗
On June 30, 2026, we entered into a definitive agreement to sell our MatrixCare business for $490 million in an all-cash transaction…View ↗
Adds restless legs treatment
The earlier report described sleep-apnea treatment; the latest report adds an acquired device that treats restless legs syndrome, extending its clinical sleep portfolio.
10-K for FY2023, filed Aug 11, 2023 10-K for FY2026, filed Aug 13, 2026Following our formation in 1989, we commercialized a treatment for obstructive sleep apnea, or OSA. This treatment, continuous positive…View ↗
Expands into home testing services
The earlier report described diagnostic products; the latest report adds a software-enabled facility that facilitates in-home and remote testing for sleep, respiratory, cardiac and other conditions.
10-K for FY2023, filed Aug 11, 2023 10-K for FY2026, filed Aug 13, 2026Since the development of CPAP, we have expanded our business by developing or acquiring a number of innovative products and solutions for a…View ↗
Through our acquisition of VirtuOx in 2025, we operate a software-enabled independent diagnostic testing facility, or IDTF, that provides…View ↗
Competes with Philips, Fisher & Paykel Healthcare, DeVilbiss Healthcare, Apex Medical, BMC Medical, React Health, Jiangsu Yuyue, and Lowenstein Medical
10-K for FY2026, filed Aug 13, 2026Our primary Sleep and Breathing Health competitors include Philips BV; Fisher & Paykel Healthcare Corporation Limited; DeVilbiss…View ↗
Loading...